MedPath

Adjunct Study of Natrelle(TM) Cohesive Round Silicone-Filled Breast Implants

Not Applicable
Completed
Conditions
Breast Reconstruction
Interventions
Device: Natrelle(TM) Silicone-Filled Breast Implants
Registration Number
NCT00691327
Lead Sponsor
Allergan Medical
Brief Summary

Safety and effectiveness of Natrelle™ Cohesive Round Silicone-Filled Breast Implants in women undergoing primary reconstruction or revision of existing breast implants.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
84329
Inclusion Criteria
  • Females of any age for which breast reconstruction is considered appropriate (Patients under 18 years old require parental/legal guardian consent to participate.
  • Females seeking revision augmentation or revision reconstruction, where problems exist
  • Have any of the following conditions or situations present:
  • Post mastectomy surgical removal of the breast for cancer or other disease;
  • Post trauma or post surgery where there was total or partial removal of the breast resulting in significant deformity;
  • Severe ptosis requiring reconstruction;
  • Any congenital or acquired discrepancy in breast size such as to represent a significant physical deformity.
  • Adequate tissue available to cover implants.
  • Saline-filled implants are not an appropriate choice.
Exclusion Criteria
  • Advanced fibrocystic disease considered to be premalignant without accompanying subcutaneous mastectomy.
  • Existing carcinoma of the breast, without mastectomy.
  • Abscess of infection in the body at the time of enrollment.
  • Pregnant or nursing.
  • Have any disease, including uncontrolled diabetes, which is clinically known to impact wound healing ability.
  • Show tissue characteristics which are clinically incompatible with mammaplasty.
  • Have, or under treatment for any condition which, in the opinion of the surgeon, may constitute an unwarranted surgical risk.
  • Are not willing to undergo further surgery for revision, if medically required.
  • Diagnosis of lupus or scleroderma.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
3Natrelle(TM) Silicone-Filled Breast ImplantsRevision-augmentation
1Natrelle(TM) Silicone-Filled Breast ImplantsPrimary reconstruction
2Natrelle(TM) Silicone-Filled Breast ImplantsRevision-reconstruction
Primary Outcome Measures
NameTimeMethod
Local Complications5 years

By patient risk of complications occurring in at least 5% of patients in 1 or more cohorts

Secondary Outcome Measures
NameTimeMethod
Satisfaction With Breast Implants as Determined by Patients and Physicians on a 5-point Scale5 years

Satisfaction score on a 5-point scale, where 1 is definitely dissatisfied and 5 is definitely satisfied

© Copyright 2025. All Rights Reserved by MedPath